Global Pathogen Reduction System Market By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction); By Application (Viruses, Bacteria, Parasites, White Blood Cells); By End User (Blood Centers, Hospitals, Others); By Product Type (Automated, Semi-Automated); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028
Industry Trends
Emerging infectious diseases coupled with rise in domestic and international travel activities has raised the risk factors in healthcare and safety department. For instance, the World Tourism Organization, a United Nations agency, stated in press release of January 2020 that international tourist arrivals across the globe grew by 4% from 2018 to 1.5 billion in 2019. Travellers are prone to be a conduit for infectious diseases. Blood products are potential cures for variety of illnesses such as cancer, infectious diseases, trauma and others. Blood transfusion is being increasingly used as cure in treatment of multiple infectious diseases, in-turn rising the demand for eliminating the risk of transfusion transmitted infection (TTI). The transfusion-transmitted infections such as Hepatitis B, Hepatitis C, HIV and others are common due to under monitored blood of donors in low and middle income countries of world. Pathogen reduction system is a potential solution to inhibit transfusion transmitted infections. In pathogen reduction system, the nucleic acids are targeted and damaged irreversibly to obstruct replication and repair of pathogens present in blood including enveloped and non-enveloped viruses, bacteria, protozoa and others. In 2014, Food and Drug Administration of U.S. approved the first pathogen reduction system for reducing the risk of transfusion transmitted infections in plasma preparation by blood establishments. Since then, blood centres, hospitals and other healthcare institutions are increasingly adopting this technology to reduce the threat of transfusion transmitted diseases, thus boosting the growth of global pathogen reduction system market.
The recent outbreak of COVID-19 has affected countries across continents and taking a death toll on more than 320,000 people worldwide. Scientists are making efforts to develop an effective vaccine for coronavirus. Amidst the absence of a proven cure, innovative treatments for curing corona patients are being explored by doctors and healthcare professionals. Treatment of coronavirus patients using plasma from recovered patients is gaining popularity among healthcare professionals and governments. Research has found that plasma from recovered patients contains antibodies which their immune system has generated to fight against the virus, which when transfused to active patient can assist to generate similar antibodies. Governments across the globe including U.K, India and others have initiated projects for testing this plasma transfusion therapy. National Health Service of U.K initiated a “Convalescent plasma programme’ in April 2020 to collect plasma from recovered coronavirus patients, voluntarily, at 23 donation centres to cure active patients. The plasma transfusion requires stringent clinical trials and removal of any pathogens present to avoid risk of transfusion transmitted infections. Pathogen reduction systems has proven successful for inactivation of coronavirus in human plasma. Also, as the blood donors are homebound due to the global shutdown to avoid spread of corona virus, scarcity in supply of blood products has aroused in many countries. Application of pathogen inactivation can increase the shelf life of platelet concentrates by 5 to 7 days, hence increasing its adoption by laboratories and hospitals. Thus, the increasing demand for avoiding transfusion transmitted infections in the COVID-19 epidemic has boosted the growth of global pathogen reduction system market.
Type Outlook:
Base on the type, plasma pathogen reduction held largest share of global pathogen reduction system market in 2019 owing to rise in research and practice of convalescent plasma therapy. This therapy was initially used for treatment of Ebola virus outbreak from 2014 to 2016. Post Ebola, scientists worked on plasma therapy for other diseases including malaria, MERS-COV and others. The growing demand for plasma in curing various health problems related to dermatology, orthopaedics, dental care and others has contributed towards the high share of plasma pathogen reduction in global pathogen reduction system market. However the platelet pathogen reduction is anticipated to grow at faster CAGR over the forecast period owing to rise in platelet transfusion treatments in caner, dengue, and other illnesses. Low platelet count results in bleeding in cancer patients which is treated by transfusion of platelets. In dengue, blood platelets are transfused to patients in response to Thrombocytopenia (a condition of low platelet count). The increasing transfusion treatments have grown the demand for pathogen reduction to avoid transfusion transmitted diseases thus boosting the growth of global pathogen reduction system market.
End User Outlook:
Based on the end users, hospitals dominated the pathogen reduction system market in 2019 across the globe owing to rise in transfusion treatments. Patients with leukaemia cancer, dengue and other illnesses are increasingly adopting blood and blood product transfusion therapies thus growing the demand for pathogen reduction system at hospitals to avoid spread of infectious diseases through transfusion. However, blood centres are anticipated to grow at fastest growth rate in global pathogen reduction system market owing to government recommendations and guidelines for using pathogen reduction technologies. For instance, a draft released by Food and Drug Administration Agency of U.S in 2017 recommends blood establishments, which collect and process blood products, to use pathogen reduction technologies approved by the FDA at their facilities to inhibit the transfusion transmitted diseases. Such initiatives are anticipated to increase the demand for pathogen reduction technologies from blood centres thus boosting the growth of global pathogen reduction system market over forecast years.
Regional Outlook:
North America region registered the highest share in global pathogen reduction system market in 2019 owing to developed healthcare infrastructure and high demand for blood and blood products. Asia Pacific is expected to register the highest growth rate over the period of next eight years owing to rise in medical tourism and blood collection. A recent press release by World Health Organization on June 2019 stated that voluntary blood donations were highest in the Asia Pacific region in 2015 with an increase of 83% from last 10 years. The rising blood collection in the region drives the demand for screening and elimination of pathogens to avoid transfusion transmitted infections. Also, the growing, critical illnesses in the Asian countries including the recent pandemic of COVID-19 has increased the blood transfusions. For instance, China accounts for about 2.2 million cancer deaths each year, as per World Health Organization estimates. These illnesses rise the blood product transfusions in the region thus contributing towards growing demand in pathogen reduction system market over the forecast period.
In terms of revenue, global pathogen reduction system market was valued at US$ 1,193.51 Mn in 2019 and is anticipated to reach US$ 5,983.31 Mn by 2028 growing at a CAGR of 19.8% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Pathogen Reduction System Market Revenue & Forecast, (US$ Million), 2015 – 2028
Competitive Landscape
The report provides both, qualitative and quantitative research of pathogen reduction system market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the pathogen reduction system market are Terumo BCT, Macopharma and Cerus Corporation amongst others. The players in this market are partnering with governments worldwide to provide pathogen reduction technology and facilitating reduction in transfusion transmitted infections. For instance, Terumo BCT has partnered with Japan International Cooperation Agency (JICA) in 2017 under a public-private partnership project to prevent transmission of infectious diseases through blood transfusion in Republic of Ghana. Such initiatives are anticipated to increase the penetration of pathogen reduction technology in low and middle income countries and hence boost the global pathogen reduction system market over forecast period.
Click on image to enlarge
Global Pathogen Reduction System Market:
- By Type
- Platelet Pathogen Reduction
- Plasma Pathogen Reduction
- By Application
- Viruses
- Bacteria
- Parasites
- White Blood Cells
- By End User
- Blood Centers
- Hospitals
- Others
- By Product Type
- Automated
- Semi-Automated
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2018
1.2.2. Base Year: 2019
1.2.3. Forecast Years: 2020 – 2028
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Pathogen Reduction Systems Market
6. Market Synopsis:
Pathogen Reduction Systems Market
7. Pathogen Reduction Systems Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Pathogen Reduction Systems Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Pathogen
Reduction Systems Market
7.6.
Porter’s Five Force
Analysis
7.7. Impact of COVID-19 on Global Pathogen Reduction Systems Market
8. Global Pathogen Reduction Systems Market Analysis and
Forecasts, 2020 – 2028
8.1. Overview
8.1.1. Global Pathogen Reduction Systems Market Revenue (US$ Mn)
8.2. Global Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
8.2.1. Platelet Pathogen Reduction
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 – 2019
8.2.1.3. Market Forecast, 2020 – 2028
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 – 2019
8.2.1.5.1.2. Market
Forecast, 2020 – 2028
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2019
8.2.1.5.2.2. Market
Forecast, 2020 – 2028
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2019
8.2.1.5.3.2. Market
Forecast, 2020 – 2028
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2019
8.2.1.5.4.2. Market
Forecast, 2020 – 2028
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 – 2019
8.2.1.5.5.2. Market
Forecast, 2020 – 2028
8.2.2. Plasma Pathogen Reduction
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 – 2019
8.2.2.3. Market Forecast, 2020 – 2028
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 – 2019
8.2.2.5.1.2. Market
Forecast, 2020 – 2028
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2019
8.2.2.5.2.2. Market
Forecast, 2020 – 2028
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2019
8.2.2.5.3.2. Market
Forecast, 2020 – 2028
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2019
8.2.2.5.4.2. Market
Forecast, 2020 – 2028
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 – 2019
8.2.2.5.5.2. Market
Forecast, 2020 – 2028
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9. Global Pathogen Reduction Systems Market Analysis and
Forecasts, 2020 – 2028
9.1. Overview
9.2. Global Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
9.2.1. Viruses
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 – 2019
9.2.1.3. Market Forecast, 2020 – 2028
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 – 2019
9.2.1.5.1.2. Market
Forecast, 2020 – 2028
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2019
9.2.1.5.2.2. Market
Forecast, 2020 – 2028
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2019
9.2.1.5.3.2. Market
Forecast, 2020 – 2028
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2019
9.2.1.5.4.2. Market
Forecast, 2020 – 2028
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 – 2019
9.2.1.5.5.2. Market
Forecast, 2020 – 2028
9.2.2. Bacteria
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 – 2019
9.2.2.3. Market Forecast, 2020 – 2028
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 – 2019
9.2.2.5.1.2. Market
Forecast, 2020 – 2028
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2019
9.2.2.5.2.2. Market
Forecast, 2020 – 2028
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2019
9.2.2.5.3.2. Market
Forecast, 2020 – 2028
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2019
9.2.2.5.4.2. Market
Forecast, 2020 – 2028
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 – 2019
9.2.2.5.5.2. Market
Forecast, 2020 – 2028
9.2.3. Parasites
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 – 2019
9.2.3.3. Market Forecast, 2020 – 2028
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 – 2019
9.2.3.5.1.2. Market
Forecast, 2020 – 2028
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 – 2019
9.2.3.5.2.2. Market
Forecast, 2020 – 2028
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 – 2019
9.2.3.5.3.2. Market
Forecast, 2020 – 2028
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 – 2019
9.2.3.5.4.2. Market
Forecast, 2020 – 2028
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 – 2019
9.2.3.5.5.2. Market
Forecast, 2020 – 2028
9.2.4. White Blood Cells
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 – 2019
9.2.4.3. Market Forecast, 2020 – 2028
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 – 2019
9.2.4.5.1.2. Market
Forecast, 2020 – 2028
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 – 2019
9.2.4.5.2.2. Market
Forecast, 2020 – 2028
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 – 2019
9.2.4.5.3.2. Market
Forecast, 2020 – 2028
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 – 2019
9.2.4.5.4.2. Market
Forecast, 2020 – 2028
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 – 2019
9.2.4.5.5.2. Market
Forecast, 2020 – 2028
9.3. Key Segment for Channeling Investments
9.3.1. By Application
10. Global Pathogen Reduction Systems Market Analysis and
Forecasts, 2020 – 2028
10.1. Overview
10.2. Global Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
10.2.1. Blood Centers
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 – 2019
10.2.1.3. Market Forecast, 2020 – 2028
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 – 2019
10.2.1.5.1.2. Market
Forecast, 2020 – 2028
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2019
10.2.1.5.2.2. Market
Forecast, 2020 – 2028
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2019
10.2.1.5.3.2. Market
Forecast, 2020 – 2028
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2019
10.2.1.5.4.2. Market
Forecast, 2020 – 2028
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 – 2019
10.2.1.5.5.2. Market
Forecast, 2020 – 2028
10.2.2. Hospitals
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 – 2019
10.2.2.3. Market Forecast, 2020 – 2028
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 – 2019
10.2.2.5.1.2. Market
Forecast, 2020 – 2028
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2019
10.2.2.5.2.2. Market
Forecast, 2020 – 2028
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2019
10.2.2.5.3.2. Market
Forecast, 2020 – 2028
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2019
10.2.2.5.4.2. Market
Forecast, 2020 – 2028
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 – 2019
10.2.2.5.5.2. Market
Forecast, 2020 – 2028
10.2.3. Others
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 – 2019
10.2.3.3. Market Forecast, 2020 – 2028
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 – 2019
10.2.3.5.1.2. Market
Forecast, 2020 – 2028
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2019
10.2.3.5.2.2. Market
Forecast, 2020 – 2028
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2019
10.2.3.5.3.2. Market
Forecast, 2020 – 2028
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2019
10.2.3.5.4.2. Market
Forecast, 2020 – 2028
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 – 2019
10.2.3.5.5.2. Market
Forecast, 2020 – 2028
10.3. Key Segment for Channeling Investments
10.3.1. By End User
11. Global Pathogen Reduction Systems Market Analysis and
Forecasts, 2020 – 2028
11.1. Overview
11.2. Global Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
11.2.1. Automated
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 – 2019
11.2.1.3. Market Forecast, 2020 – 2028
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 – 2019
11.2.1.5.1.2. Market
Forecast, 2020 – 2028
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2019
11.2.1.5.2.2. Market
Forecast, 2020 – 2028
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2019
11.2.1.5.3.2. Market
Forecast, 2020 – 2028
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2019
11.2.1.5.4.2. Market
Forecast, 2020 – 2028
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 – 2019
11.2.1.5.5.2. Market
Forecast, 2020 – 2028
11.2.2. Semi-Automated
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 – 2019
11.2.2.3. Market Forecast, 2020 – 2028
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 – 2019
11.2.2.5.1.2. Market
Forecast, 2020 – 2028
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2019
11.2.2.5.2.2. Market
Forecast, 2020 – 2028
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2019
11.2.2.5.3.2. Market
Forecast, 2020 – 2028
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2019
11.2.2.5.4.2. Market
Forecast, 2020 – 2028
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 – 2019
11.2.2.5.5.2. Market
Forecast, 2020 – 2028
11.3. Key Segment for Channeling Investments
11.3.1. By Product Type
12. North America Pathogen Reduction Systems Market Analysis and
Forecasts, 2020 - 2028
12.1. Overview
12.1.1. North America Pathogen Reduction Systems Market Revenue (US$
Mn)
12.2. North America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Type
12.2.1. Platelet Pathogen Reduction
12.2.2. Plasma Pathogen Reduction
12.3. North America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Application
12.3.1. Viruses
12.3.2. Bacteria
12.3.3. Parasites
12.3.4. White Blood Cells
12.4. North America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By End User
12.4.1. Blood Centers
12.4.2. Hospitals
12.4.3. Others
12.5. North America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Product Type
12.5.1. Automated
12.5.2. Semi-Automated
12.6. North America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.1.1.1. Platelet Pathogen Reduction
12.6.1.1.2. Plasma Pathogen Reduction
12.6.1.2. U.S Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.1.2.1. Viruses
12.6.1.2.2. Bacteria
12.6.1.2.3. Parasites
12.6.1.2.4. White Blood Cells
12.6.1.3. U.S Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.3.1. Blood Centers
12.6.1.3.2. Hospitals
12.6.1.3.3. Others
12.6.1.4. U.S Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.6.1.4.1. Automated
12.6.1.4.2. Semi-Automated
12.6.2. Canada
12.6.2.1. Canada Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.2.1.1. Platelet Pathogen Reduction
12.6.2.1.2. Plasma Pathogen Reduction
12.6.2.2. Canada Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.2.1. Viruses
12.6.2.2.2. Bacteria
12.6.2.2.3. Parasites
12.6.2.2.4. White Blood Cells
12.6.2.3. Canada Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.2.3.1. Blood Centers
12.6.2.3.2. Hospitals
12.6.2.3.3. Others
12.6.2.4. Canada Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.6.2.4.1. Automated
12.6.2.4.2. Semi-Automated
12.6.3. Mexico
12.6.3.1. Mexico Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.3.1.1. Platelet Pathogen Reduction
12.6.3.1.2. Plasma Pathogen Reduction
12.6.3.2. Mexico Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.2.1. Viruses
12.6.3.2.2. Bacteria
12.6.3.2.3. Parasites
12.6.3.2.4. White Blood Cells
12.6.3.3. Mexico Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.3.1. Blood Centers
12.6.3.3.2. Hospitals
12.6.3.3.3. Others
12.6.3.4. Mexico Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.6.3.4.1. Automated
12.6.3.4.2. Semi-Automated
12.6.4. Rest of North America
12.6.4.1. Rest of North America Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Type
12.6.4.1.1. Platelet Pathogen Reduction
12.6.4.1.2. Plasma Pathogen Reduction
12.6.4.2. Rest of North America Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Application
12.6.4.2.1. Viruses
12.6.4.2.2. Bacteria
12.6.4.2.3. Parasites
12.6.4.2.4. White Blood Cells
12.6.4.3. Rest of North America Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By End User
12.6.4.3.1. Blood Centers
12.6.4.3.2. Hospitals
12.6.4.3.3. Others
12.6.4.4. Rest of North America Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.6.4.4.1. Automated
12.6.4.4.2. Semi-Automated
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Type
12.7.3. By Application
12.7.4. By End User
12.7.5. By Product Type
13. Europe Pathogen Reduction Systems Market Analysis and
Forecasts, 2020 - 2028
13.1. Overview
13.1.1. Europe Pathogen Reduction Systems Market Revenue (US$ Mn)
13.2. Europe Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
13.2.1. Platelet Pathogen Reduction
13.2.2. Plasma Pathogen Reduction
13.3. Europe Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
13.3.1. Viruses
13.3.2. Bacteria
13.3.3. Parasites
13.3.4. White Blood Cells
13.4. Europe Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
13.4.1. Blood Centers
13.4.2. Hospitals
13.4.3. Others
13.5. Europe Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.5.1. Automated
13.5.2. Semi-Automated
13.6. Europe Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.1. France
13.6.1.1. France Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.1.1.1. Platelet Pathogen Reduction
13.6.1.1.2. Plasma Pathogen Reduction
13.6.1.2. France Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.2.1. Viruses
13.6.1.2.2. Bacteria
13.6.1.2.3. Parasites
13.6.1.2.4. White Blood Cells
13.6.1.3. France Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.3.1. Blood Centers
13.6.1.3.2. Hospitals
13.6.1.3.3. Others
13.6.1.4. France Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.1.4.1. Automated
13.6.1.4.2. Semi-Automated
13.6.2. The UK
13.6.2.1. The UK Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.2.1.1. Platelet Pathogen Reduction
13.6.2.1.2. Plasma Pathogen Reduction
13.6.2.2. The UK Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.2.2.1. Viruses
13.6.2.2.2. Bacteria
13.6.2.2.3. Parasites
13.6.2.2.4. White Blood Cells
13.6.2.3. The UK Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.2.3.1. Blood Centers
13.6.2.3.2. Hospitals
13.6.2.3.3. Others
13.6.2.4. The UK Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.2.4.1. Automated
13.6.2.4.2. Semi-Automated
13.6.3. Spain
13.6.3.1. Spain Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.3.1.1. Platelet Pathogen Reduction
13.6.3.1.2. Plasma Pathogen Reduction
13.6.3.2. Spain Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.3.2.1. Viruses
13.6.3.2.2. Bacteria
13.6.3.2.3. Parasites
13.6.3.2.4. White Blood Cells
13.6.3.3. Spain Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.3.3.1. Blood Centers
13.6.3.3.2. Hospitals
13.6.3.3.3. Others
13.6.3.4. Spain Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.3.4.1. Automated
13.6.3.4.2. Semi-Automated
13.6.4. Germany
13.6.4.1. Germany Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.4.1.1. Platelet Pathogen Reduction
13.6.4.1.2. Plasma Pathogen Reduction
13.6.4.2. Germany Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.4.2.1. Viruses
13.6.4.2.2. Bacteria
13.6.4.2.3. Parasites
13.6.4.2.4. White Blood Cells
13.6.4.3. Germany Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.4.3.1. Blood Centers
13.6.4.3.2. Hospitals
13.6.4.3.3. Others
13.6.4.4. Germany Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.4.4.1. Automated
13.6.4.4.2. Semi-Automated
13.6.5. Italy
13.6.5.1. Italy Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.5.1.1. Platelet Pathogen Reduction
13.6.5.1.2. Plasma Pathogen Reduction
13.6.5.2. Italy Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.5.2.1. Viruses
13.6.5.2.2. Bacteria
13.6.5.2.3. Parasites
13.6.5.2.4. White Blood Cells
13.6.5.3. Italy Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.5.3.1. Blood Centers
13.6.5.3.2. Hospitals
13.6.5.3.3. Others
13.6.5.4. Italy Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.5.4.1. Automated
13.6.5.4.2. Semi-Automated
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By Type
13.6.6.1.1. Platelet Pathogen Reduction
13.6.6.1.2. Plasma Pathogen Reduction
13.6.6.2. Nordic Countries Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.6.2.1. Viruses
13.6.6.2.2. Bacteria
13.6.6.2.3. Parasites
13.6.6.2.4. White Blood Cells
13.6.6.3. Nordic Countries Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By End User
13.6.6.3.1. Blood Centers
13.6.6.3.2. Hospitals
13.6.6.3.3. Others
13.6.6.4. Nordic Countries Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By Product Type
13.6.6.4.1. Automated
13.6.6.4.2. Semi-Automated
13.6.6.5. Nordic Countries Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Type
13.6.7.1.1. Platelet Pathogen Reduction
13.6.7.1.2. Plasma Pathogen Reduction
13.6.7.2. Benelux Union Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Application
13.6.7.2.1. Viruses
13.6.7.2.2. Bacteria
13.6.7.2.3. Parasites
13.6.7.2.4. White Blood Cells
13.6.7.3. Benelux Union Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By End User
13.6.7.3.1. Blood Centers
13.6.7.3.2. Hospitals
13.6.7.3.3. Others
13.6.7.4. Benelux Union Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Product Type
13.6.7.4.1. Automated
13.6.7.4.2. Semi-Automated
13.6.7.5. Benelux Union Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Type
13.6.8.1.1. Platelet Pathogen Reduction
13.6.8.1.2. Plasma Pathogen Reduction
13.6.8.2. Rest of Europe Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Application
13.6.8.2.1. Viruses
13.6.8.2.2. Bacteria
13.6.8.2.3. Parasites
13.6.8.2.4. White Blood Cells
13.6.8.3. Rest of Europe Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By End User
13.6.8.3.1. Blood Centers
13.6.8.3.2. Hospitals
13.6.8.3.3. Others
13.6.8.4. Rest of Europe Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Product Type
13.6.8.4.1. Automated
13.6.8.4.2. Semi-Automated
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Type
13.7.3. By Application
13.7.4. By End User
13.7.5. By Product Type
14. Asia Pacific Pathogen Reduction Systems Market Analysis and
Forecasts, 2020 - 2028
14.1. Overview
14.1.1. Asia Pacific Pathogen Reduction Systems Market Revenue (US$
Mn)
14.2. Asia Pacific Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Type
14.2.1. Platelet Pathogen Reduction
14.2.2. Plasma Pathogen Reduction
14.3. Asia Pacific Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Application
14.3.1. Viruses
14.3.2. Bacteria
14.3.3. Parasites
14.3.4. White Blood Cells
14.4. Asia Pacific Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By End User
14.4.1. Blood Centers
14.4.2. Hospitals
14.4.3. Others
14.5. Asia Pacific Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Product Type
14.5.1. Automated
14.5.2. Semi-Automated
14.6. Asia Pacific Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.1.1.1. Platelet Pathogen Reduction
14.6.1.1.2. Plasma Pathogen Reduction
14.6.1.2. China Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.1.2.1. Viruses
14.6.1.2.2. Bacteria
14.6.1.2.3. Parasites
14.6.1.2.4. White Blood Cells
14.6.1.3. China Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.1.3.1. Blood Centers
14.6.1.3.2. Hospitals
14.6.1.3.3. Others
14.6.1.4. China Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.6.1.4.1. Automated
14.6.1.4.2. Semi-Automated
14.6.2. Japan
14.6.2.1. Japan Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.2.1.1. Platelet Pathogen Reduction
14.6.2.1.2. Plasma Pathogen Reduction
14.6.2.2. Japan Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.2.2.1. Viruses
14.6.2.2.2. Bacteria
14.6.2.2.3. Parasites
14.6.2.2.4. White Blood Cells
14.6.2.3. Japan Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.2.3.1. Blood Centers
14.6.2.3.2. Hospitals
14.6.2.3.3. Others
14.6.2.4. Japan Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.6.2.4.1. Automated
14.6.2.4.2. Semi-Automated
14.6.3. India
14.6.3.1. India Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.3.1.1. Platelet Pathogen Reduction
14.6.3.1.2. Plasma Pathogen Reduction
14.6.3.2. India Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.3.2.1. Viruses
14.6.3.2.2. Bacteria
14.6.3.2.3. Parasites
14.6.3.2.4. White Blood Cells
14.6.3.3. India Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.3.3.1. Blood Centers
14.6.3.3.2. Hospitals
14.6.3.3.3. Others
14.6.3.4. India Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.6.3.4.1. Automated
14.6.3.4.2. Semi-Automated
14.6.4. New Zealand
14.6.4.1. New Zealand Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Type
14.6.4.1.1. Platelet Pathogen Reduction
14.6.4.1.2. Plasma Pathogen Reduction
14.6.4.2. New Zealand Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.4.2.1. Viruses
14.6.4.2.2. Bacteria
14.6.4.2.3. Parasites
14.6.4.2.4. White Blood Cells
14.6.4.3. New Zealand Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.4.3.1. Blood Centers
14.6.4.3.2. Hospitals
14.6.4.3.3. Others
14.6.4.4. New Zealand Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Product Type
14.6.4.4.1. Automated
14.6.4.4.2. Semi-Automated
14.6.5. Australia
14.6.5.1. Australia Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Type
14.6.5.1.1. Platelet Pathogen Reduction
14.6.5.1.2. Plasma Pathogen Reduction
14.6.5.2. Australia Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.5.2.1. Viruses
14.6.5.2.2. Bacteria
14.6.5.2.3. Parasites
14.6.5.2.4. White Blood Cells
14.6.5.3. Australia Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.5.3.1. Blood Centers
14.6.5.3.2. Hospitals
14.6.5.3.3. Others
14.6.5.4. Australia Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Product Type
14.6.5.4.1. Automated
14.6.5.4.2. Semi-Automated
14.6.6. South Korea
14.6.6.1. South Korea Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Type
14.6.6.1.1. Platelet Pathogen Reduction
14.6.6.1.2. Plasma Pathogen Reduction
14.6.6.2. South Korea Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.6.2.1. Viruses
14.6.6.2.2. Bacteria
14.6.6.2.3. Parasites
14.6.6.2.4. White Blood Cells
14.6.6.3. South Korea Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.6.3.1. Blood Centers
14.6.6.3.2. Hospitals
14.6.6.3.3. Others
14.6.6.4. South Korea Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Product Type
14.6.6.4.1. Automated
14.6.6.4.2. Semi-Automated
14.6.7. Southeast Asia
14.6.7.1. Southeast Asia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Type
14.6.7.1.1. Platelet Pathogen Reduction
14.6.7.1.2. Plasma Pathogen Reduction
14.6.7.2. Southeast Asia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Application
14.6.7.2.1. Viruses
14.6.7.2.2. Bacteria
14.6.7.2.3. Parasites
14.6.7.2.4. White Blood Cells
14.6.7.3. Southeast Asia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By End User
14.6.7.3.1. Blood Centers
14.6.7.3.2. Hospitals
14.6.7.3.3. Others
14.6.7.4. Southeast Asia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Product Type
14.6.7.4.1. Automated
14.6.7.4.2. Semi-Automated
14.6.7.5. Southeast Asia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1. Rest of Asia Pacific Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By Type
14.6.8.1.1. Platelet Pathogen Reduction
14.6.8.1.2. Plasma Pathogen Reduction
14.6.8.2. Rest of Asia Pacific Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.8.2.1. Viruses
14.6.8.2.2. Bacteria
14.6.8.2.3. Parasites
14.6.8.2.4. White Blood Cells
14.6.8.3. Rest of Asia Pacific Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By End User
14.6.8.3.1. Blood Centers
14.6.8.3.2. Hospitals
14.6.8.3.3. Others
14.6.8.4. Rest of Asia Pacific Pathogen Reduction Systems Market Revenue
(US$ Mn) and Forecasts, By Product Type
14.6.8.4.1. Automated
14.6.8.4.2. Semi-Automated
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Type
14.7.3. By Application
14.7.4. By End User
14.7.5. By Product Type
15. Middle East and Africa Pathogen Reduction Systems Market
Analysis and Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Middle East and Africa Pathogen Reduction Systems Market
Revenue (US$ Mn)
15.2. Middle East and Africa Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Type
15.2.1. Platelet Pathogen Reduction
15.2.2. Plasma Pathogen Reduction
15.3. Middle East and Africa Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Application
15.3.1. Viruses
15.3.2. Bacteria
15.3.3. Parasites
15.3.4. White Blood Cells
15.4. Middle East and Africa Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By End User
15.4.1. Blood Centers
15.4.2. Hospitals
15.4.3. Others
15.5. Middle East and Africa Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Product Type
15.5.1. Automated
15.5.2. Semi-Automated
15.6. Middle East and Africa Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Type
15.6.1.1.1. Platelet Pathogen Reduction
15.6.1.1.2. Plasma Pathogen Reduction
15.6.1.2. Saudi Arabia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Application
15.6.1.2.1. Viruses
15.6.1.2.2. Bacteria
15.6.1.2.3. Parasites
15.6.1.2.4. White Blood Cells
15.6.1.3. Saudi Arabia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By End User
15.6.1.3.1. Blood Centers
15.6.1.3.2. Hospitals
15.6.1.3.3. Others
15.6.1.4. Saudi Arabia Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Product Type
15.6.1.4.1. Automated
15.6.1.4.2. Semi-Automated
15.6.2. UAE
15.6.2.1. UAE Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.2.1.1. Platelet Pathogen Reduction
15.6.2.1.2. Plasma Pathogen Reduction
15.6.2.2. UAE Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.2.2.1. Viruses
15.6.2.2.2. Bacteria
15.6.2.2.3. Parasites
15.6.2.2.4. White Blood Cells
15.6.2.3. UAE Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.2.3.1. Blood Centers
15.6.2.3.2. Hospitals
15.6.2.3.3. Others
15.6.2.4. UAE Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.6.2.4.1. Automated
15.6.2.4.2. Semi-Automated
15.6.3. Egypt
15.6.3.1. Egypt Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.3.1.1. Platelet Pathogen Reduction
15.6.3.1.2. Plasma Pathogen Reduction
15.6.3.2. Egypt Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.3.2.1. Viruses
15.6.3.2.2. Bacteria
15.6.3.2.3. Parasites
15.6.3.2.4. White Blood Cells
15.6.3.3. Egypt Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.3.3.1. Blood Centers
15.6.3.3.2. Hospitals
15.6.3.3.3. Others
15.6.3.4. Egypt Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.6.3.4.1. Automated
15.6.3.4.2. Semi-Automated
15.6.4. Kuwait
15.6.4.1. Kuwait Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.4.1.1. Platelet Pathogen Reduction
15.6.4.1.2. Plasma Pathogen Reduction
15.6.4.2. Kuwait Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.4.2.1. Viruses
15.6.4.2.2. Bacteria
15.6.4.2.3. Parasites
15.6.4.2.4. White Blood Cells
15.6.4.3. Kuwait Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.4.3.1. Blood Centers
15.6.4.3.2. Hospitals
15.6.4.3.3. Others
15.6.4.4. Kuwait Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.6.4.4.1. Automated
15.6.4.4.2. Semi-Automated
15.6.5. South Africa
15.6.5.1. South Africa Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Type
15.6.5.1.1. Platelet Pathogen Reduction
15.6.5.1.2. Plasma Pathogen Reduction
15.6.5.2. South Africa Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Application
15.6.5.2.1. Viruses
15.6.5.2.2. Bacteria
15.6.5.2.3. Parasites
15.6.5.2.4. White Blood Cells
15.6.5.3. South Africa Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By End User
15.6.5.3.1. Blood Centers
15.6.5.3.2. Hospitals
15.6.5.3.3. Others
15.6.5.4. South Africa Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Product Type
15.6.5.4.1. Automated
15.6.5.4.2. Semi-Automated
15.6.6. Rest of Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Pathogen Reduction Systems
Market Revenue (US$ Mn) and Forecasts, By Type
15.6.6.1.1. Platelet Pathogen Reduction
15.6.6.1.2. Plasma Pathogen Reduction
15.6.6.2. Rest of Middle East & Africa Pathogen Reduction Systems
Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.2.1. Viruses
15.6.6.2.2. Bacteria
15.6.6.2.3. Parasites
15.6.6.2.4. White Blood Cells
15.6.6.3. Rest of Middle East & Africa Pathogen Reduction Systems
Market Revenue (US$ Mn) and Forecasts, By End User
15.6.6.3.1. Blood Centers
15.6.6.3.2. Hospitals
15.6.6.3.3. Others
15.6.6.4. Rest of Middle East & Africa Pathogen Reduction Systems
Market Revenue (US$ Mn) and Forecasts, By Product Type
15.6.6.4.1. Automated
15.6.6.4.2. Semi-Automated
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Type
15.7.3. By Application
15.7.4. By End User
15.7.5. By Product Type
16. Latin America Pathogen Reduction Systems Market Analysis and
Forecasts, 2020 - 2028
16.1. Overview
16.1.1. Latin America Pathogen Reduction Systems Market Revenue (US$
Mn)
16.2. Latin America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Type
16.2.1. Platelet Pathogen Reduction
16.2.2. Plasma Pathogen Reduction
16.3. Latin America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Application
16.3.1. Viruses
16.3.2. Bacteria
16.3.3. Parasites
16.3.4. White Blood Cells
16.4. Latin America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By End User
16.4.1. Blood Centers
16.4.2. Hospitals
16.4.3. Others
16.5. Latin America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Product Type
16.5.1. Automated
16.5.2. Semi-Automated
16.6. Latin America Pathogen Reduction Systems Market Revenue (US$
Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Type
16.6.1.1.1. Platelet Pathogen Reduction
16.6.1.1.2. Plasma Pathogen Reduction
16.6.1.2. Brazil Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.1.2.1. Viruses
16.6.1.2.2. Bacteria
16.6.1.2.3. Parasites
16.6.1.2.4. White Blood Cells
16.6.1.3. Brazil Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.1.3.1. Blood Centers
16.6.1.3.2. Hospitals
16.6.1.3.3. Others
16.6.1.4. Brazil Pathogen Reduction Systems Market Revenue (US$ Mn) and
Forecasts, By Product Type
16.6.1.4.1. Automated
16.6.1.4.2. Semi-Automated
16.6.2. Argentina
16.6.2.1. Argentina Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Type
16.6.2.1.1. Platelet Pathogen Reduction
16.6.2.1.2. Plasma Pathogen Reduction
16.6.2.2. Argentina Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Application
16.6.2.2.1. Viruses
16.6.2.2.2. Bacteria
16.6.2.2.3. Parasites
16.6.2.2.4. White Blood Cells
16.6.2.3. Argentina Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By End User
16.6.2.3.1. Blood Centers
16.6.2.3.2. Hospitals
16.6.2.3.3. Others
16.6.2.4. Argentina Pathogen Reduction Systems Market Revenue (US$ Mn)
and Forecasts, By Product Type
16.6.2.4.1. Automated
16.6.2.4.2. Semi-Automated
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Type
16.6.3.1.1. Platelet Pathogen Reduction
16.6.3.1.2. Plasma Pathogen Reduction
16.6.3.2. Rest of Latin America Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Application
16.6.3.2.1. Viruses
16.6.3.2.2. Bacteria
16.6.3.2.3. Parasites
16.6.3.2.4. White Blood Cells
16.6.3.3. Rest of Latin America Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By End User
16.6.3.3.1. Blood Centers
16.6.3.3.2. Hospitals
16.6.3.3.3. Others
16.6.3.4. Rest of Latin America Pathogen Reduction Systems Market
Revenue (US$ Mn) and Forecasts, By Product Type
16.6.3.4.1. Automated
16.6.3.4.2. Semi-Automated
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Type
16.7.3. By Application
16.7.4. By End User
16.7.5. By Product Type
17. Competitive Benchmarking
17.1. Market Share Analysis, 2018
17.2. Global Presence and Growth Strategies
17.2.1. Mergers and Acquisitions
17.2.2. Product Launches
17.2.3. Investments Trends
17.2.4. R&D Initiatives
18. Player Profiles
18.1. Cerus Corporation.
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Macopharma
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. TERUMO BCT, INC.
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. Other Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.